Skip to content
Open access

Determinants of seasonal influenza and COVID-19 vaccine uptake in high-risk individuals in northern Sweden

Jul 2026 · Human Vaccines & Immunotherapeutics · Vol 22 · 0 citations · 45 references
Medicine

TL;DR

Targeted communication, such as risk-stacking to improve risk-awareness, harmonized eligibility criteria, and co-administration, may help overcome remaining vaccination barriers in high-risk individuals.

Abstract

ABSTRACT Seasonal influenza and COVID-19 vaccination in high-risk individuals prevent disease, disability, and death. Nevertheless, many high-income countries continue to experience suboptimal vaccine coverage. We therefore aimed to identify the remaining vaccination barriers in these settings. We recruited patients seeking emergency department care at a hospital in northern Sweden. Using semi-structured interviews and medical records, we collected high-resolution individual-level data, and linked community-level determinants from national registers. Logistic regression was used to calculate odds ratios (OR) and adjusted odds ratios (aOR) for determinants associated with influenza and COVID-19 vaccination. We included 600 patients of whom 450 were eligible for both vaccines. Coverage among eligible individuals was 52.0% for influenza and 54.2% for COVID-19. Co-administration of both vaccines was high (OR 55.33, 95% CI: 30.86–99.22). Individual-level determinants associated with lower vaccine uptake included male biological sex (aOR: 0.57, 95% CI: 0.37–0.88, younger age (aOR: 0.50, 95% CI: 0.41–0.61), smoking (aOR: 0.43, 95% CI: 0.18–1.02), reduced independence (aOR: 0.59, 95% CI: 0.31–1.10), and age-only eligibility (aOR 0.41, 95% CI: 0.19–0.86). In multimorbid individuals, meeting more eligibility criteria showed no significant association with higher uptake (aOR: 1.14, 95% CI: 0.93–1.39). Finally, we noted only limited influence of community-level determinants. In conclusion, vaccine uptake for influenza and COVID-19 was primarily associated with individual-level determinants, whereas community-level showed little impact. Targeted communication, such as risk-stacking to improve risk-awareness, harmonized eligibility criteria, and co-administration, may help overcome remaining vaccination barriers in high-risk individuals.

Read PDF

Similar papers

Review Open access Jul 2026

Determinants of influenza vaccination in a French primary care population in the post-COVID-19 era.

In this primary care survey, influenza vaccination during the 2022-2023 season was primarily associated with prior influenza vaccination history, suggesting persistence of vaccination practices over time and targeted strategies that reinforce continuity and encourage initiation among previously unvaccinated adults coul...

S. Mafi, A. Billo, M. Durieux et al. · 0 citations
Jul 2026

Uptake of Influenza, Pneumococcal, and COVID-19 Vaccines Among People Living with HIV: Findings from the Ontario HIV Treatment Network Cohort Study.

Across all three vaccines, uptake remains below national targets in people living with HIV in Ontario, particularly for those at highest risk of severe respiratory infections, and interventions that address predisposing, enabling, and need factors associated with vaccine uptake may help improve access and promote vacci...

C. Chambers, T. Bekele, R. Grewal et al. · 0 citations
Open access Aug 2026

Influenza Vaccination and Symptom Burden in Ambulatory Patients with Confirmed Influenza: Evidence from Case-ascertained Household Transmission Studies.

Ambulatory children with influenza who were vaccinated experienced less ILI symptom burden compared to those who were not vaccinated against influenza, but vaccination was not associated with symptom duration.

Amanda C Howa, Yu-Wei Zhu, T. McGonigle et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.